Non-randomised trial, 2022
Does S-equol supplement help reduce premenstrual symptoms?
S-equol showed only a small benefit for premenstrual symptoms, with improvement related to gut bacteria composition.
What they did
20 women with premenstrual symptoms (who don't naturally produce equol from soy) took an S-equol supplement for two menstrual cycles. Symptoms were measured before and during treatment using the Daily Record of Severity of Problems questionnaire. Researchers also analyzed their gut bacteria before treatment.
What they found
Only 10.5% of women showed at least 50% improvement in symptoms. However, overall analysis showed improvement in symptom scores and in four key PMDD symptoms. Women whose improvement was greatest had higher Bifidobacterium and lower Clostridium cluster IV bacteria in their gut.
What it means for you
S-equol supplements may help some women with premenstrual symptoms, but only a small number respond well. The gut bacteria may play a role in whether the supplement works. This is a very small pilot study with no control group, so much more research is needed.
20
Women in study
10.5%
With at least 50% improvement in symptoms
4
Core PMDD symptoms improved
About the study
- Original title
- Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open-label pilot study
- Authors
- Takeda T, Chiba Y
- Journal
- Neuropsychopharmacology reports
- Year
- 2022
- Study design
- Non-randomised trial
- What was tested
- Oral S-equol supplement for two menstrual cycles
- Open access
- Yes
- Read the paper
- doi.org/10.1002/npr2.12234
Original abstract
Aim: Premenstrual syndrome causes disturbances in many women's daily activities. Isoflavones might cause changes in the estrogen cycle by their selective estrogen receptor modulator-like activities. Equol, which is a metabolite of a soy isoflavone, has greater biological activity than other soy isoflavones. In this preliminary study, we aimed to examine the effect of a natural S-equol supplement (SE5-OH) on premenstrual symptoms. The gut microbiota has recently been suggested to play an important role in brain function in psychiatric disease, such as depression. Therefore, we further aimed to evaluate the relationship of the effect of SE5-OH and the gut microbiota at preintervention. Methods: Twenty women who showed premenstrual symptoms and were nonequol producers were enrolled in an open-label, single-arm, clinical study in which they received oral SE5-OH for two period cycles. The Daily Record of Severity of Problems (DRSP) total score was evaluated during the intervention cycles. Before taking SE5-OH, fecal samples were obtained and subjected to terminal restriction fragment length polymorphism analysis. Results: The response rate to treatment (≥50% reduction from baseline in the DRSP total score) was 10.5%. Post hoc analysis showed a significant improvement in the change in the DRSP total score (P = .008) and DRSP scores for four core premenstrual dysphoric disorder symptoms. Multiple regression analysis showed that the percentage improvement of the DRSP total score was positively related to Bifidobacterium and negatively related to Clostridium cluster IV. Conclusion: SE5-OH supplementation may be an acceptable treatment for premenstrual symptoms. The intestinal microbiota may have an effect on SE5-OH.
Reproduced under CC-BY.
Topics
Related studies
Systematic review, 2025
How common are PMS, PMDD, and painful periods in nursing students, and do they affect their schooling?
Review, 2001
What causes PMS and PMDD, and how are they treated?
Randomised trial, 2024
Does a banana drink with egg white reduce PMDD symptoms and improve mood?
Survey study, 2023
What factors make some women more likely to have PMS or PMDD?
Survey study, 2019
What lifestyle and sleep habits are linked to PMS in teenage girls?
Case-control study, 2018
Do women with PMDD crave different foods than healthy women?